Companies / Frekil
Frekril provides an AI real-world evidence platform that automates post-approval observational studies, including post-marketing safety, HEOR and market access, label expansion, and external comparator work. It serves pharmaceutical teams and researchers who need regulator-, HTA-, and payer-standard evidence.
Summarized from its homepage on 12 Nov 2026.
San Francisco, CA, US
Vendors of Frekil and the evidence for each
Amazon CloudFrontCloud and infrastructureLikely
CloudflareCloud and infrastructureLikely
Google WorkspaceProductivityLikely
Next.jsDeveloper toolsLikely
No public list found
We did not find a public subprocessor list. The company may still publish one, or share it privately.
Certifications
| Standard | What the source says | Checked |
|---|---|---|
| HIPAACompany's statement | “This separation is a hard architectural boundary, not a configuration option, and Frekil is HIPAA and GDPR compliant.”The company's own statement of compliance. There is no official HIPAA certification or registry. | 13 Nov 2026Source |
We last read its homepage on 13 Nov 2026 and the FedRAMP Marketplace on 8 Nov 2026. A standard not shown here was not found in these sources. That does not mean Frekil lacks it.
Vendor's own statement, retrieved from the source URL on the date shown. StrataDB does not verify the underlying claim. Data sources.
See Frekil's full stack
Every vendor with its source and date, and an alert when Frekil adds or drops one. The same lookup works for any company.
- Every company and vendor, with its public source
- 100 API calls a month, plus MCP and the Chrome extension
- Work email only. No card, no sales call